In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen
about
High-throughput chemical screen identifies a novel potent modulator of cellular circadian rhythms and reveals CKIα as a clock regulatory kinaseSpiroindolones, a potent compound class for the treatment of malariaUse of high-density tiling microarrays to identify mutations globally and elucidate mechanisms of drug resistance in Plasmodium falciparumThe malaria parasite cation ATPase PfATP4 and its role in the mechanism of action of a new arsenal of antimalarial drugsNext-generation antimicrobials: from chemical biology to first-in-class drugsGlobal phenotypic screening for antimalarialsOpen Source Drug Discovery: Highly Potent Antimalarial Compounds Derived from the Tres Cantos ArylpyrrolesRecent advances in malaria drug discoveryUsing genetic methods to define the targets of compounds with antimalarial activityNovel Inhibitors of Plasmodium falciparum Dihydroorotate Dehydrogenase with Anti-malarial Activity in the Mouse ModelDesign and Synthesis of Inhibitors of Plasmodium falciparumN -Myristoyltransferase, A Promising Target for Antimalarial Drug DiscoveryAntimalarial drug discovery - approaches and progress towards new medicines.Gift from Nature: Cyclomarin A Kills Mycobacteria and Malaria Parasites by Distinct Modes of ActionAnalogs of natural aminoacyl-tRNA synthetase inhibitors clear malaria in vivoMutations in the P-Type Cation-Transporter ATPase 4, PfATP4, Mediate Resistance to Both Aminopyrazole and Spiroindolone AntimalarialsIdentification of an Atg8-Atg3 protein-protein interaction inhibitor from the medicines for Malaria Venture Malaria Box active in blood and liver stage Plasmodium falciparum parasitesImaging of Plasmodium Liver Stages to Drive Next-Generation Antimalarial Drug DiscoveryTargeting Plasmodium PI(4)K to eliminate malariaIn silico characterization of an atypical MAPK phosphatase of Plasmodium falciparum as a suitable target for drug discoveryMuddled mechanisms: recent progress towards antimalarial target identificationChEMBL: a large-scale bioactivity database for drug discoveryPhenotypic screens, chemical genomics, and antimalarial lead discoveryIntegrated dataset of screening hits against multiple neglected disease pathogensP. falciparum in vitro killing rates allow to discriminate between different antimalarial mode-of-actionA chemocentric approach to the identification of cancer targetsAgrochemicals against malaria, sleeping sickness, leishmaniasis and Chagas diseaseMitotic evolution of Plasmodium falciparum shows a stable core genome but recombination in antigen familiesA new in vivo screening paradigm to accelerate antimalarial drug discoveryPrediction of the P. falciparum target space relevant to malaria drug discoveryExploring the mode of action of bioactive compounds by microfluidic transcriptional profiling in mycobacteriaUtilizing Chemical Genomics to Identify Cytochrome b as a Novel Drug Target for Chagas DiseaseA New Set of Chemical Starting Points with Plasmodium falciparum Transmission-Blocking Potential for Antimalarial Drug DiscoveryBiochemical Screening of Five Protein Kinases from Plasmodium falciparum against 14,000 Cell-Active CompoundsDiscovery of New Compounds Active against Plasmodium falciparum by High Throughput Screening of Microbial Natural ProductsHemozoin and antimalarial drug discoveryHigh-Throughput Luciferase-Based Assay for the Discovery of Therapeutics That Prevent MalariaOptiMal-PK: an internet-based, user-friendly interface for the mathematical-based design of optimized anti-malarial treatment regimensChemical genetics of Plasmodium falciparumThe Malaria Parasite's Lactate Transporter PfFNT Is the Target of Antiplasmodial Compounds Identified in Whole Cell Phenotypic ScreensNatural products as starting points for future anti-malarial therapies: going back to our roots?
P2860
Q21563543-EA57AD77-13D0-483D-8E51-02C738BB58E9Q24606915-90612FA9-6537-46FE-B99F-F84E973EC317Q24653974-D7D2FD12-A1D1-42C6-87A1-6F7995EE5FAAQ26781634-78245E26-DD51-4DC9-8187-91AF066ABF26Q26799749-40558F94-D636-482C-8D13-D9EE630FFE27Q26824875-F6B06B42-E063-461C-8374-F2DCA015B295Q26883657-806A6AF7-1ACC-421C-9A1B-F2884C180AA9Q27010534-6BC29A33-1B4B-490A-BEC3-60490DF69057Q27014788-25AA4807-874F-4906-92BF-D92251E70BD7Q27664030-7D202A4F-9E9A-453F-9583-B45F5160741CQ27674217-D3F3D219-D96E-4E25-859F-676C497C64AEQ27693245-097D6E94-8C62-44CC-B146-BCD2C5EC3A96Q27702304-03327A94-8A6D-4871-82D4-4F5A3F6B3A0FQ27861933-F68EA08A-03BC-42EE-A7C4-D411FFD93ACFQ27861952-715AAC24-88F4-4F1A-AA60-21E76A52587DQ27861954-12E0DF55-586D-4F20-B644-41366A486AC8Q27861956-7FAC759E-9AEC-4B72-80CB-2B3999FBD54AQ27974482-0C1DA527-074E-493D-AA9B-639A95D767E3Q27974727-66813A92-FCBC-4DD7-85D4-82EE6302A82AQ28066421-D6ED27D2-384C-4542-ADB9-5CED82635678Q28315179-8136B852-7BD0-4E19-9D1A-BDC45BBB5A8BQ28476619-961CD64E-75AA-44C6-9B11-3C513A0F972BQ28478485-1560CA90-1FD1-4BDA-BF0A-4287B4EEBE44Q28481199-B79662CC-9AC2-4F01-90B6-A9CAF0DBFA7AQ28482507-5BF9D5D2-4A90-49F6-AC2F-C33687B04764Q28484975-89C03179-D652-4C9F-B1C2-4F51FECF84C4Q28486079-F71A570F-60A4-4055-A4D1-602A20F6E798Q28534314-41E3FA39-2374-4AC9-8A26-7F1608D38FD9Q28534474-2057FA11-8D24-44F0-86D2-0E9B3B5DE6D2Q28535015-FC3301AC-7BDA-4CF1-B671-9B6FC88B0A7AQ28546644-951FE3F6-E688-4E89-BEF6-9DBFA60C4550Q28547546-7D81904C-3816-4C15-BE01-F1D4B8E55481Q28550478-963458A6-08A1-4F9C-85B3-C23B85F91477Q28552116-16EA0232-9F30-4737-AF67-90A124D8B38EQ28828253-3680B08B-EBE3-48EB-8CDC-B229EB5F3D71Q28829342-BC5F6ACF-FA61-4341-8D9B-360DEE1A9DB0Q28831110-5489B187-9B99-4D70-A38D-1D7FA3FAAB25Q29617272-87A129B3-8221-48CF-90BA-32CA3404BA38Q30042965-1F76AE3B-025D-453D-9CE8-3B188A873707Q30396384-61F5839F-15CB-453F-93BF-015433568173
P2860
In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
In silico activity profiling r ...... ed in a high-throughput screen
@ast
In silico activity profiling r ...... ed in a high-throughput screen
@en
type
label
In silico activity profiling r ...... ed in a high-throughput screen
@ast
In silico activity profiling r ...... ed in a high-throughput screen
@en
prefLabel
In silico activity profiling r ...... ed in a high-throughput screen
@ast
In silico activity profiling r ...... ed in a high-throughput screen
@en
P2093
P2860
P356
P1476
In silico activity profiling r ...... ed in a high-throughput screen
@en
P2093
Achim Brinker
Advait Nagle
Arnab Chatterjee
Case McNamara
David Plouffe
Francisco Adrián
Jason T Matzen
Jeff Janes
Jeremy S Caldwell
Kelli Kuhen
P2860
P304
P356
10.1073/PNAS.0802982105
P407
P577
2008-06-25T00:00:00Z